Skip to main content

Animations

MJFF Publications

641 - 650 of 7939 Results
Title
Year
  • Year
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • OPEN
    Title: CSF proteome profiling reveals biomarkers to discriminate dementia with Lewy bodies from Alzheimer´s disease
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-023-41122-y
    Citation Count: 18
  • OPEN
    Title: Defining the causes of sporadic Parkinson’s disease in the global Parkinson’s genetics program (GP2)
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-023-00533-w
    Citation Count: 8
  • OPEN
    Title: Neurofilament light chain as a mediator between LRRK2 mutation and dementia in Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-023-00572-3
    Citation Count: 6
  • OPEN
    Title: Parkinson's disease pathology is directly correlated to SIRT3 in human subjects and animal models: Implications for AAV.SIRT3-myc as a disease-modifying therapy
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nbd.2023.106287
    Citation Count: 2
  • OPEN
    Title: Early and Accurate Diagnosis of Parkinson Disease May Be Rooted in Seed Amplification Assays
    Journal Name: Clinical Chemistry
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/clinchem/hvad111
    Citation Count: 1
  • OPEN
    Title: Functional Brain Networks to Evaluate Treatment Responses in Parkinson's Disease
    Journal Name: Neurotherapeutics
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s13311-023-01433-w
    Best OA location URL:
    Citation Count: 1
  • OPEN
    Title: The Effects of Subthalamic Nucleus Deep Brain Stimulation and Retention Delay on Memory-Guided Reaching Performance in People with Parkinson’s Disease
    Journal Name: Journal of Parkinson's Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.3233/jpd-225041
    Citation Count: 0
  • RESTRICTED
    Title: CXCR6 orchestrates brain CD8+ T cell residency and limits mouse Alzheimer’s disease pathology
    Journal Name: Nature Immunology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1038/s41590-023-01604-z
    Best OA location URL:
    Citation Count: 44
  • OPEN
    Title: Measuring Up: A Comparison of TapeStation 4200 and Bioanalyzer 2100 as Measurement Tools for RNA Quality in Postmortem Human Brain Samples
    Journal Name: International Journal of Molecular Sciences
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/ijms241813795
    Citation Count: 3
  • OPEN
    Title: Prediagnostic Blood Metal Levels and the Risk of Parkinson's Disease: A Large European Prospective Cohort
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.29602
    Citation Count: 2
Filters
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.